Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Trends & Forecasts

Under Construction: Pharma's Cannabinoid Bid

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave with cannabis-based medicines? And how will drugmakers entering the fray deal with the dosage, delivery and bioavailability challenges?

Business & Regulation Standards & Regulation

The IPEC Story: Promoting Ingredients for Success

| With David Schoneker

High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry. Today, IPEC is helping to give excipients the recognition they deserve.

Discovery & Development Drug Discovery

Benevolent Action

| Maryam Mahdi

A partnership formed between Action Against AMD and BenovolentAI is helping to identify drugs for the treatment of AMD, he leading cause of sight loss in the developed world.

Register to personalize your newsfeed

Create Account

Latest Articles

Manufacture Packaging

The Smart Pill Bottle

| Maryam Mahdi

Could a text message make all the difference in ensuring the integrity of drug products?

Business & Regulation Business Practice

Solutions In... Human Antibodies

| Maryam Mahdi

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

Business & Regulation Standards & Regulation

Cutting Out the Middleman

| Maryam Mahdi

What are the consequences of allowing patients to purchase cell and gene therapies directly from hospitals?

Business & Regulation Trends & Forecasts

Aid Africa

| Stephanie Sutton

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

Discovery & Development Formulation

Choosing the Right Excipients for the Right Job

| Rob Harris

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Discovery & Development Drug Discovery

The Killer Combo

| Anthony Coates

Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?

Discovery & Development Drug Discovery

Solutions In... Nanoparticles

| Maryam Mahdi

Why are spherical nucleic acids so exciting for drug development?

Discovery & Development Drug Discovery

Bright SPARK

| Maryam Mahdi

Representing a powerful example of collaboration between industry and academia is SPARK – a program helping accelerate the drug development process.

Discovery & Development Drug Discovery

Treasures of the Deep

| Maryam Mahdi

Could aquatic bacteria hold the keys to bolstering our drug pipelines?

Business & Regulation Business Practice


| Maryam Mahdi

Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?

All Articles


Send me the latest from The Medicine Maker.

Sign up now

Upcoming Events


CPhI & P-MEC China 2019 at SNIEC, Shanghai, China

Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the...


4th PDA Europe Annual Meeting

Amsterdam, The Netherlands

This conference has the aim to identify ways of improving patients‘ health and welfare by sharing best-practice...


Chemspec Europe 2019

Messe Basel, Switzerland

Chemspec Europe will take place from 26 – 27 June 2019 at Messe Basel in Switzerland. The 34th edition of the...

All Events

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine